In a recent study, researchers have looked at the question of whether blueberry consumption could improve the clinical outcomes, functioning, and overall quality of life of individuals with functional gastrointestinal disorders (FGID).
FGID impact 10-15% of most populations and often involves functional dyspepsia and irritable bowel syndrome (IBS). While the specific mechanisms of FGID remain unclear, certain factors, such as sensitization of the nervous system, gut permeability modulation, immune activation, and enteric microbiome changes, are thought to be interrelated and impacted by dietary factors.
In the present study, researchers examine the impact of blueberry consumption on the laboratory measures and clinical symptoms of FGID. The polyphenol and dietary fiber content of blueberries can significantly reduce abdominal pain and improve the quality of life in FGID patients.
